AR and metabolic dysfunction-associated steatotic liver disease: Together these data indicate that inhibition of AR caused activation of hepatic PPARα to alter the expression and activity of major hepatic enzymes involved in lipid homeostasis in the T2DM db/db mice, which might have significant impact on hepatic lipid accumulation and the development or progression of NASH and NAFLD.